Is IPOT.CN undervalued or overvalued?

As of 2025-03-26, the Intrinsic Value of Isracann Biosciences Inc (IPOT.CN) is -0.13 CAD. This IPOT.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.02 CAD, the upside of Isracann Biosciences Inc is -963.67%. This means that IPOT.CN is overvalued by 963.67%.

Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.

	Range	Selected	Upside
a
Fair Value	-0.13 - -0.13	-0.13	-963.67%
P/E	(0.00) - (0.02)	(0.00)	-117.3%
DDM - Stable	(0.39) - (4.76)	(2.58)	-17275.0%
DDM - Multi	(0.40) - (3.79)	(0.73)	-4940.9%